Full Coverage

- By relevance
- By date

Share

Fosun Pharma partners with Teva Pharmaceutical for cancer treatment

Teva and Fosun Pharma Enter into a Strategic Partnership to Develop Novel Anti-PD1-IL2 Therapy (TEV-56278) in Immuno-Oncology

5 days ago

More

Teva Pharmaceutical, Shanghai Fosun Partner to Develop Cancer Treatment Drug

5 days ago

More

Teva and Fosun Pharma partner on early-stage oncology drug

3 days ago

By Emily Kimber

More

Teva, Fosun in pact for cancer drug (TEVA) (TEVA:NYSE)

5 days ago

By Nilanjana Basu

More

Teva Partners With Fosun to Develop TEV-56278 Immuno-Cancer Therapy

4 days ago

More

Contract Pharma

Teva, Fosun Pharma Partner to Develop Immuno-Oncology Therapy

5 days ago

By Rachel Klemovitch

More

Teva, Fosun enter strategic partnership to develop TEV-56278

5 days ago

More

Teva to collaborate with Fosun Pharma for TEV-56278

4 days ago

More

Following

Saved searches

Your local news

Language & regionEnglish (United States)

Settings

Get the Android app

Get the iOS app

Send feedback

Privacy · Terms · About Google

Search

Clear search

Close search

Google apps

Main menu